Regulatory Open Forum

Prescription drugs, cosmetics, food supplements, and over-the-counter medicines sold in Indonesia will be required to bear state of the art identification systems under regulations being finalized by the country's regulatory authority, the National Agency of Drug and Food Control (BADAN POM).

By 2025, pharmaceutical companies will be required to mark all prescription drug products with 2D codes that ensure they can be tracked and traced. The regulations, which begin to be phased into effect in 2023,  also require drug packaging to bear an authentication barcode.

The new identification requirements have been in the works for several years, and are intended to improve the safety and quality of drugs marketed in Indonesia.

Prescription drugs, cosmetics, food supplements, and over-the-counter medicines sold in Indonesia will be required to bear state of the art identification systems under regulations being finalized by the country's regulatory authority, the National Agency of Drug and Food Control (BADAN POM).

By 2025, pharmaceutical companies will be required to mark all prescription drug products with 2D codes that ensure they can be tracked and traced. The regulations, which begin to be phased into effect in 2023,  also require drug packaging to bear an authentication barcode.

The new identification requirements have been in the works for several years, and are intended to improve the safety and quality of drugs marketed in Indonesia.

Prescription drugs, cosmetics, food supplements, and over-the-counter medicines sold in Indonesia will be required to bear state of the art identification systems under regulations being finalized by the country's regulatory authority, the National Agency of Drug and Food Control (BADAN POM).

By 2025, pharmaceutical companies will be required to mark all prescription drug products with 2D codes that ensure they can be tracked and traced. The regulations, which begin to be phased into effect in 2023,  also require drug packaging to bear an authentication barcode.

The new identification requirements have been in the works for several years, and are intended to improve the safety and quality of drugs marketed in Indonesia.

Prescription drugs, cosmetics, food supplements, and over-the-counter medicines sold in Indonesia will be required to bear state of the art identification systems under regulations being finalized by the country's regulatory authority, the National Agency of Drug and Food Control (BADAN POM).

By 2025, pharmaceutical companies will be required to mark all prescription drug products with 2D codes that ensure they can be tracked and traced. The regulations, which begin to be phased into effect in 2023,  also require drug packaging to bear an authentication barcode.

The new identification requirements have been in the works for several years, and are intended to improve the safety and quality of drugs marketed in Indonesia.